nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.301	0.344	CbGbCtD
Zafirlukast—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.16	0.183	CbGbCtD
Zafirlukast—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.134	0.154	CbGbCtD
Zafirlukast—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.112	0.128	CbGbCtD
Zafirlukast—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.102	0.117	CbGbCtD
Zafirlukast—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.065	0.0743	CbGbCtD
Zafirlukast—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00733	0.0985	CcSEcCtD
Zafirlukast—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.0549	CcSEcCtD
Zafirlukast—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.0475	CcSEcCtD
Zafirlukast—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.0436	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.0406	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.0404	CcSEcCtD
Zafirlukast—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.0356	CcSEcCtD
Zafirlukast—CYSLTR2—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.00261	0.0506	CbGpPWpGaD
Zafirlukast—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.0345	CcSEcCtD
Zafirlukast—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00255	0.0495	CbGpPWpGaD
Zafirlukast—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0305	CcSEcCtD
Zafirlukast—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.0296	CcSEcCtD
Zafirlukast—CYSLTR2—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.00218	0.0423	CbGpPWpGaD
Zafirlukast—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.029	CcSEcCtD
Zafirlukast—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.0279	CcSEcCtD
Zafirlukast—CYSLTR1—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.00181	0.0351	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—EDN1—focal segmental glomerulosclerosis	0.00169	0.0328	CbGpPWpGaD
Zafirlukast—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0221	CcSEcCtD
Zafirlukast—CYSLTR1—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.00151	0.0293	CbGpPWpGaD
Zafirlukast—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0201	CcSEcCtD
Zafirlukast—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.02	CcSEcCtD
Zafirlukast—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0193	CcSEcCtD
Zafirlukast—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.0185	CcSEcCtD
Zafirlukast—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0184	CcSEcCtD
Zafirlukast—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0184	CcSEcCtD
Zafirlukast—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0183	CcSEcCtD
Zafirlukast—CYSLTR1—Endothelins—EDN1—focal segmental glomerulosclerosis	0.00117	0.0227	CbGpPWpGaD
Zafirlukast—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0149	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00109	0.0212	CbGpPWpGaD
Zafirlukast—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0147	CcSEcCtD
Zafirlukast—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0145	CcSEcCtD
Zafirlukast—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0137	CcSEcCtD
Zafirlukast—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0137	CcSEcCtD
Zafirlukast—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0135	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000978	0.019	CbGpPWpGaD
Zafirlukast—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000974	0.0131	CcSEcCtD
Zafirlukast—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000968	0.013	CcSEcCtD
Zafirlukast—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000954	0.0128	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000914	0.0177	CbGpPWpGaD
Zafirlukast—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000887	0.0119	CcSEcCtD
Zafirlukast—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000881	0.0118	CcSEcCtD
Zafirlukast—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000857	0.0115	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.0113	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000841	0.0163	CbGpPWpGaD
Zafirlukast—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00084	0.0113	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.000836	0.0162	CbGpPWpGaD
Zafirlukast—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.0112	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000818	0.0159	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.0108	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000796	0.0107	CcSEcCtD
Zafirlukast—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000789	0.0153	CbGpPWpGaD
Zafirlukast—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.0104	CcSEcCtD
Zafirlukast—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.0104	CcSEcCtD
Zafirlukast—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.0104	CcSEcCtD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.000758	0.0147	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000748	0.0145	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00072	0.014	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000718	0.00965	CcSEcCtD
Zafirlukast—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000714	0.0138	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000709	0.0137	CbGpPWpGaD
Zafirlukast—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000699	0.00939	CcSEcCtD
Zafirlukast—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000689	0.00926	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000678	0.0131	CbGpPWpGaD
Zafirlukast—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000666	0.00896	CcSEcCtD
Zafirlukast—CYSLTR2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000647	0.0125	CbGpPWpGaD
Zafirlukast—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.00866	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000634	0.0123	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.000634	0.0123	CbGpPWpGaD
Zafirlukast—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000619	0.00833	CcSEcCtD
Zafirlukast—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00826	CcSEcCtD
Zafirlukast—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00825	CcSEcCtD
Zafirlukast—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00061	0.0082	CcSEcCtD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000589	0.0114	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000583	0.0113	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00058	0.0112	CbGpPWpGaD
Zafirlukast—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000579	0.00778	CcSEcCtD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000567	0.011	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000554	0.0107	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000549	0.0106	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000526	0.0102	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000518	0.01	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000499	0.00968	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.000491	0.00952	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00047	0.0091	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000448	0.00868	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00044	0.00852	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000429	0.00832	CbGpPWpGaD
Zafirlukast—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000423	0.0082	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000422	0.00817	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.000408	0.00791	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000396	0.00766	CbGpPWpGaD
Zafirlukast—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00039	0.00755	CbGpPWpGaD
Zafirlukast—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000389	0.00754	CbGpPWpGaD
Zafirlukast—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.000388	0.00752	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000384	0.00744	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00038	0.00737	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000365	0.00707	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000358	0.00693	CbGpPWpGaD
Zafirlukast—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00033	0.00639	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000325	0.00631	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000312	0.00604	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00031	0.00601	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.0003	0.00581	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000297	0.00575	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000293	0.00568	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000292	0.00567	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000283	0.00549	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000281	0.00546	CbGpPWpGaD
Zafirlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00027	0.00524	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000269	0.00522	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000261	0.00505	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000252	0.00489	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000248	0.0048	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000238	0.00462	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000237	0.00459	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000227	0.00441	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000221	0.00428	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000216	0.00419	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000216	0.00419	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000215	0.00416	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000206	0.00399	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000203	0.00393	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000202	0.00392	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000196	0.0038	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000195	0.00378	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000193	0.00373	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000192	0.00373	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000187	0.00362	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000184	0.00356	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000181	0.0035	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000168	0.00325	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000167	0.00324	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000166	0.00322	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000165	0.0032	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000164	0.00318	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000158	0.00306	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000152	0.00295	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00015	0.00291	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00014	0.00271	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00014	0.00271	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000128	0.00248	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000127	0.00247	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000116	0.00225	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000116	0.00225	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000115	0.00223	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000108	0.0021	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000108	0.00209	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000106	0.00205	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000105	0.00204	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000104	0.00201	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.96e-05	0.00193	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.69e-05	0.00188	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.49e-05	0.00184	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	9.18e-05	0.00178	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9e-05	0.00174	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.86e-05	0.00172	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.31e-05	0.00161	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.51e-05	0.00146	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.29e-05	0.00141	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.96e-05	0.00135	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.92e-05	0.00134	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.91e-05	0.00134	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.58e-05	0.00128	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.24e-05	0.00121	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.22e-05	0.0012	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.13e-05	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.76e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.67e-05	0.0011	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.63e-05	0.00109	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.47e-05	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.3e-05	0.00103	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—LIPC—focal segmental glomerulosclerosis	5e-05	0.000969	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.99e-05	0.000967	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.84e-05	0.000939	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.8e-05	0.000931	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.8e-05	0.000929	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.4e-05	0.000853	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.37e-05	0.000846	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.32e-05	0.000837	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.27e-05	0.000828	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.26e-05	0.000826	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.25e-05	0.000824	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.23e-05	0.000819	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.05e-05	0.000786	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.89e-05	0.000755	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.79e-05	0.000735	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.67e-05	0.000712	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.64e-05	0.000705	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.59e-05	0.000695	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.46e-05	0.00067	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.25e-05	0.000629	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.16e-05	0.000612	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	3.1e-05	0.000601	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	3.05e-05	0.000591	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.03e-05	0.000587	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.96e-05	0.000573	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.96e-05	0.000573	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	2.93e-05	0.000568	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.91e-05	0.000564	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.79e-05	0.000541	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	2.77e-05	0.000537	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	2.73e-05	0.000529	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	2.61e-05	0.000506	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.55e-05	0.000493	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.53e-05	0.00049	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.52e-05	0.000489	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.52e-05	0.000488	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	2.51e-05	0.000486	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.49e-05	0.000483	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	2.44e-05	0.000472	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.27e-05	0.00044	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.25e-05	0.000435	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.24e-05	0.000434	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.22e-05	0.000431	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	2.19e-05	0.000424	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.16e-05	0.000418	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.07e-05	0.0004	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.05e-05	0.000397	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	2e-05	0.000388	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.94e-05	0.000376	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.92e-05	0.000373	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.9e-05	0.000368	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.89e-05	0.000367	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	1.87e-05	0.000363	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.75e-05	0.000339	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.69e-05	0.000327	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.66e-05	0.000323	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	1.62e-05	0.000314	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.55e-05	0.000301	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.54e-05	0.000299	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.47e-05	0.000284	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.45e-05	0.00028	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	1.44e-05	0.000279	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.35e-05	0.000262	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.33e-05	0.000258	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.32e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.32e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.24e-05	0.000241	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.13e-05	0.000218	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.11e-05	0.000215	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.02e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.02e-05	0.000197	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.01e-05	0.000196	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	8.69e-06	0.000168	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	8.64e-06	0.000167	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.67e-06	0.000129	CbGpPWpGaD
